CSL Limited Enters Flu Vaccine Market
Filed in archive Corporate and Industrial News , Drugs, Vaccines and Therapeutics on February 7, 2006

CSL Limited, An Australian pharmaceutical company, is planning to enter the flu vaccine market in 2007. The company is planning to file for regualtory approval early next year, in time for the flu season in fall 2007 and spring 2008.
CSL is confident that there is room for them in the marketplace, considering that the other big pharma companies such as Sanofi pasteur, GlaxoSmithKline and Chiron are revving up their productions. MedImmune even had a nasal spray version of the flu vaccine developed.
McNamee [CSL's chief executive said] said CSL provides geographical and seasonal diversity as a supplier - Australia's flu season peaks in July and August, compared with January and February for the U.S. - which gives the company leverage when another manufacturer experiences production problems.
CSL also is testing a prototype for a bird flu vaccine that could be ready within two years.
The public can just benefit from more companies producing flu vaccines (or any other product for that matter), right?
Read full story from SeattlePI.com.

CSL also is testing a prototype for a bird flu vaccine that could be ready within two years.
Permalink: CSL Limited Enters Flu Vaccine Market
Tags: flu vaccine biotech market enters enters+vaccine vaccine+market limited+enters
Vote for CSL Limited Enters Flu Vaccine Market:
|
Rating: 6.00 out of 4 vote(s) cast.
|
Most Popular
Best of
Biotech Hubs and Facilities
Biotech/Science Blogs
Corporate and Industrial News
Diagnostics, Methodologies and Instrumentation
Did you know
Drugs, Vaccines and Therapeutics
Energy, Environment and Ecology
Food and Agriculture
Gene Therapy
Genomics, Proteomics and Bioinformatics
Information About
Meetings and Other Events
Microbiology
Misc
Nanomedicine
Other Biotechnology News
Patents and Intellectual Property Rights
Quick introduction
Stem Cells
